Image from Google Jackets

The delivery of regenerative medicines and their impact on healthcare edited by Catherine Prescott and Dame Julia Polak.

By: Polak, Dame Julia | Prescott, C. D | Polak, Julia MMaterial type: TextTextPublication details: Boca Raton, London, New York CRC Press/Taylor & Francis 2011Description: 400p. HbkISBN: 9781439836064 Subject(s): Health Care Sector | Regenerative Medicine | Tissue engineering - Economic aspects | Regenerative medicine - Economic aspects | Medical care - Economic aspectsDDC classification: 610.28 PRE
Contents:
(Publisher-supplied data) WHAT IS REGENERATIVE MEDICINE / Julia Polak -- A NEW POLITICAL-FINANCIAL PARADIGM FOR MEDICAL RESEARCH: THE CALIFORNIA USA MODEL / Robert Klein/Alan Trounson -- INVESTMENT MODELS 4. PUBLIC FUNDING IN AUSTRALIA / Graham Macdonald -- CANADA: CAPITALISING ON A 50-YEAR LEGACY / Andrew Lyall -- INVESTING IN REGENERATIVE MEDICINE: WHAT DRIVES THE PRIVATE INVESTOR? / Cathy Prescott -- PUBLIC INVESTMENT MODELS: COMING OUT OF THE CLOSET AND GOING PUBLIC! / Reni Benjamin -- CELL-BASED PRODUCTS: ALLOGENIC / Paul Kemp -- AUTOLOGOUS CELL BASED PRODUCTS: FULFILLING THE PROMISE OF CELL THERAPY / Eduardo Bravo, Magdalena Blanco-Molina -- BUSINESS MODELS FOR CORD BLOOD / Suzanne Watt -- CHANGING THE GAME OF DRUG DISCOVERY / John Walker -- DISCOVERY OF SMALL MOLECULE REGENERATIVE DRUGS / Yen Choo -- THE ADOPTION OF THERAPEUTIC STEM CELL TECHNOLOGIES BY LARGE PHARMACEUTICAL COMPANIES / Alain Vertes -- ROLE OF TOOLS AND TECHNOLOGIES COMPANIES IN THE SUCCESSFUL COMMERCIALIZATION OF REGENERATIVE MEDICINE / Joydeep Goswami -- KEY CONSIDERATIONS IN MANUFACTURING OF CELLULAR THERAPIES / Robert Preti -- STATE OF THE GLOBAL REGENERATIVE MEDICINE INDUSTRY / Lee Buckler, R. Margolin, S. Haecker -- REGENERATING IP: EUROPE AFTER WARF Julian Hitchcock and Devanand Crease -- PROTECTING REGENERATIVE MEDICINE INTELLECTUAL PROPERTY IN THE USE: PROBLEMS AND STRATEGIES / David Resnick, Ronald Eisenstein, Joseph McWilliams -- IMPACT OF INDIAN POLICIES AND LAWS ON REGENERATIVE MEDICINE PATENT APPLICATIONS / Prabuddha Ganguli -- A CATalyst FOR CHANGE: REGULATING REGENERATIVE MEDICINES IN EUROPE / Christopher Bravery -- THE US REGULATORY REIMBURSEMENT POLITICAL ENVIRONMENT AND STRATEGIES FOR REFORM / Michael Werner.
Summary: "Based on input from an international panel of experts, this book provides first-hand experience of the challenges and opportunities facing the delivery of regenerative medicines to patients. It highlights key issues beyond science and clinical translation, such as finance and business models, intellectual property and regulatory landscapes as well as questions of how regenerative medicines will be evaluated for reimbursement. This book will become a pivotal reference to anyone within the healthcare sector interested in understanding and investing in the delivery of regenerative medicines to the benefit of patients"--Provided by publisher.
Holdings
Item type Current library Home library Class number Status Date due Barcode Item reservations
Book Book Ruskin College Library Ruskin College Library 610.28 PRE (Browse shelf(Opens below)) Available R53650X0085
Total reservations: 0

<p>Includes bibliographical references and index.</p>

(Publisher-supplied data) WHAT IS REGENERATIVE MEDICINE / Julia Polak -- A NEW POLITICAL-FINANCIAL PARADIGM FOR MEDICAL RESEARCH: THE CALIFORNIA USA MODEL / Robert Klein/Alan Trounson -- INVESTMENT MODELS 4. PUBLIC FUNDING IN AUSTRALIA / Graham Macdonald -- CANADA: CAPITALISING ON A 50-YEAR LEGACY / Andrew Lyall -- INVESTING IN REGENERATIVE MEDICINE: WHAT DRIVES THE PRIVATE INVESTOR? / Cathy Prescott -- PUBLIC INVESTMENT MODELS: COMING OUT OF THE CLOSET AND GOING PUBLIC! / Reni Benjamin -- CELL-BASED PRODUCTS: ALLOGENIC / Paul Kemp -- AUTOLOGOUS CELL BASED PRODUCTS: FULFILLING THE PROMISE OF CELL THERAPY / Eduardo Bravo, Magdalena Blanco-Molina -- BUSINESS MODELS FOR CORD BLOOD / Suzanne Watt -- CHANGING THE GAME OF DRUG DISCOVERY / John Walker -- DISCOVERY OF SMALL MOLECULE REGENERATIVE DRUGS / Yen Choo -- THE ADOPTION OF THERAPEUTIC STEM CELL TECHNOLOGIES BY LARGE PHARMACEUTICAL COMPANIES / Alain Vertes -- ROLE OF TOOLS AND TECHNOLOGIES COMPANIES IN THE SUCCESSFUL COMMERCIALIZATION OF REGENERATIVE MEDICINE / Joydeep Goswami -- KEY CONSIDERATIONS IN MANUFACTURING OF CELLULAR THERAPIES / Robert Preti -- STATE OF THE GLOBAL REGENERATIVE MEDICINE INDUSTRY / Lee Buckler, R. Margolin, S. Haecker -- REGENERATING IP: EUROPE AFTER WARF Julian Hitchcock and Devanand Crease -- PROTECTING REGENERATIVE MEDICINE INTELLECTUAL PROPERTY IN THE USE: PROBLEMS AND STRATEGIES / David Resnick, Ronald Eisenstein, Joseph McWilliams -- IMPACT OF INDIAN POLICIES AND LAWS ON REGENERATIVE MEDICINE PATENT APPLICATIONS / Prabuddha Ganguli -- A CATalyst FOR CHANGE: REGULATING REGENERATIVE MEDICINES IN EUROPE / Christopher Bravery -- THE US REGULATORY REIMBURSEMENT POLITICAL ENVIRONMENT AND STRATEGIES FOR REFORM / Michael Werner.

"Based on input from an international panel of experts, this book provides first-hand experience of the challenges and opportunities facing the delivery of regenerative medicines to patients. It highlights key issues beyond science and clinical translation, such as finance and business models, intellectual property and regulatory landscapes as well as questions of how regenerative medicines will be evaluated for reimbursement. This book will become a pivotal reference to anyone within the healthcare sector interested in understanding and investing in the delivery of regenerative medicines to the benefit of patients"--Provided by publisher.

There are no comments on this title.

to post a comment.